Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Harvest Technologies Corporation Files Amended Patent Infringement Complaint against ThermoGenesis Corporation and Celling



 Harvest Technologies Corporation Files Amended Patent Infringement Complaint
        against ThermoGenesis Corporation and Celling Technologies LLC

PR Newswire

PLYMOUTH, Mass., Feb. 20, 2013

PLYMOUTH, Mass., Feb. 20, 2013 /PRNewswire/ --  Harvest Technologies
Corporation (Harvest) announced that it filed an amended patent infringement
complaint on February 15, 2013 in the US District Court of Delaware against
ThermoGenesis Corporation (ThermoGenesis) and Celling Technologies LLC.  The
complaint was amended to include Celling Technologies and alleges that the
ThermoGenesis' Res-Q™ 60 BMC system, also sold by Celling Technologies as the
ART 21^® BMC System, infringes two patents for which Harvest Technology owns
the rights.  These patents relate to Harvest's proprietary floating shelf
technology that has been shown in studies to provide superior cellular
concentration.  The complaint also requests an injunction against further
sales of the product in the U.S.

"Harvest Technologies has invested many years and millions of dollars in
development of its cellular therapy products," said Gael Tisack, Vice
President of Intellectual Property for Terumo Americas Holding.  "We will
continue to take all steps necessary to ensure that we protect our
intellectual property and enforce our patent rights."

Harvest Technologies is the leading cellular therapy global manufacturer that
has developed       point-of-care products to process and concentrate multiple
biologics.  These include high-density platelet rich plasma (APC^+^®), bone
marrow aspirate concentrate (BMAC^®) and adipose tissue.  The company is
headquartered in Plymouth, Massachusetts.  It is one of several subsidiaries
of Terumo Corporation of Japan that is focused in cellular therapies and
biologics.  For more information, visit www.harvesttech.com or call
508-732-7500.

Tokyo-based Terumo Corporation is one of the world's leading medical device
manufacturers with    $5 billion in sales and operations in more than 160
nations. Founded in 1921, the company develops, manufactures, and distributes
world-class medical devices including products for use in cardiothoracic
surgery, interventional procedures, and transfusion medicine; the company also
manufactures a broad array of syringe and hypodermic needle products for
hospital and physician office use.

Harvest is a registered trademark of Harvest Technologies Corporation. 
Terumo^® is a registered trademark of Terumo Corporation. Res-Q is a trademark
of ThermoGenesis Corporation.  Celling Technologies^® is a registered
trademark of Celling Technologies LLC.  ART 21 is a trademark of Celling
Technologies^®

SOURCE Harvest Technologies Corporation

Contact: Michele Sullivan, Director of Marketing, Harvest Technologies
Corporation, +1-508-732-7500
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement